K. Gabriel

Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery

E. Viscusi, L. Techner, T. Witkowski, 2006, Surgical Endoscopy And Other Interventional Techniques.

Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery

N. Hyman, C. Delaney, J. Weese, 2005, Diseases of the colon and rectum.

Alvimopan, a Novel, Peripherally Acting μ Opioid Antagonist: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Major Abdominal Surgery and Postoperative Ileus

L. Techner, F. Michelassi, B. Wolff, 2004, Annals of surgery.

A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy.

R. Coleman, T. Herzog, L. Techner, 2006, American journal of obstetrics and gynecology.

Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery

N. Hyman, C. Delaney, J. Weese, 2005, Diseases of the colon and rectum.